| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | Chief Medical Officer | Common Stock | 4K | $2.24K | $0.56 | Nov 14, 2022 | Direct |
| Aeglea BioTherapeutics, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 550K | Feb 23, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AGLE | Aeglea BioTherapeutics, Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 24, 2023 | Chief Medical Officer |
| AGLE | Aeglea BioTherapeutics, Inc. | Nov 14, 2022 | 1 | $0 | 4 | Jan 27, 2023 | Chief Medical Officer |
| AGLE | Aeglea BioTherapeutics, Inc. | Nov 14, 2022 | 0 | $0 | 3 | Jan 27, 2023 | Chief Medical Officer |